Dermatology News

During the 2021 match cycle, a presence on Twitter and having specialized training tracks were associated with a higher likelihood of filling infectious disease fellowships programs, researchers found.

HIV captured me during my first clinical rotation in medical school, early in the Plague Years, around the same time that AIDS was getting its name from CDC.

I never had any intention of pursuing a career in infectious diseases — or medicine for that matter.

IDWeek, originally planned for San Diego, will be an all-virtual meeting for the second year in a row because of COVID-19.

I began my training at the beginning of the HIV pandemic. I still remember a lecture during my second year of medical school in which a young man told us that his friends were dying of a new disease called gay-related immunodeficiency disease, subsequently known as AIDS.

In the wake of the COVID-19 pandemic, data indicate that there has been a surge in interest among U.S. college students in pursuing medicine as a career.

I chose ID as a medical specialty because of the intellectual stimulation and investigative nature that accompanies the study of microbes within humans.

The FDA approved the AbbVie’s Dalvance (dalbavancin) for the treatment of acute bacterial skin and skin structure infections in pediatric patients from birth, according to a press release.

On my first day of medical school, I was assigned a physical diagnosis tutor who was a well-known infectious diseases specialist. He had encyclopedic knowledge. He was a remarkable teacher and — equally important — a great storyteller.

My initial fascination with infectious diseases began as it did for many others: through the influence of my parents and exposure through books.